Opaleye Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Opaleye Management’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-90,000	Closed	-$7.91M	–	52
2015 Q2	$7.91M	Sell	90,000 -50,000	-36%	-$4.28M	3.15%	10
2015 Q1	$10.4M	Hold	140,000	–	–	4.82%	5
2014 Q4	$7.84M	Hold	140,000	–	–	3.96%	7
2014 Q3	$6.21M	Buy	140,000 +10,000	+8%	+$418K	4.84%	6
2014 Q2	$5.37M	Buy	+130,000	New	+$6.7M	4.63%	9

Other funds holding CLVS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Antipodean Advisors New York $19.5M AUM 6.21% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Opaleye Management's CLVS Position: Q3 2015 in Review

Opaleye Management sold out of Clovis Oncology, Inc. (CLVS) in Q3 2015, closing a stake of 90,000 shares — an estimated $7.91M sold.

Opaleye Management first reported a position in CLVS in Q2 2014 and held it in 5 quarters. The position peaked at $10.4M in Q1 2015. 192 funds tracked by Wall St. Rank hold CLVS as of Q3 2015.

Opaleye Management reported no remaining Clovis Oncology, Inc. position as of Q3 2015 after selling out during the quarter.
Opaleye Management sold 90,000 Clovis Oncology, Inc. shares in Q3 2015, an estimated $7.91M.
Opaleye Management first reported a position in Clovis Oncology, Inc. in Q2 2014 and held it in 5 quarters.
Opaleye Management's Clovis Oncology, Inc. position peaked at $10.4M in Q1 2015.
192 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q3 2015.

Based on Opaleye Management's 13F filing for Q3 2015, filed 13 Nov 2015.